Biotech: A Coming Boom — or Bust?
Biotech: A Coming Boom — or Bust?
Two industry veterans lay out contrasting views about what the sector and its investors can expect over the next 12 months.
Biotech: A Coming Boom — or Bust?
Two industry veterans lay out contrasting views about what the sector and its investors can expect over the next 12 months.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Leave a Reply
Want to join the discussion?Feel free to contribute!